Radnor Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.7M Sell
518,900
-543
-0.1% -$63.6K 9.36% 1
2026
Q1
$62.5M Sell
519,443
-115
-0% -$13.3K 9.25% 1
2025
Q4
$54.7M Sell
519,558
-1,491
-0.3% -$140K 8.12% 1
2025
Q3
$43.7M Sell
521,049
-1,659
-0.3% -$137K 6.65% 1
2025
Q2
$41.4M Buy
522,708
+15,210
+3% +$1.21M 6.6% 1
2025
Q1
$45.6M Sell
507,498
-13,268
-3% -$1.24M 7.63% 1
2024
Q4
$51.8M Sell
520,766
-9,744
-2% -$1M 8.66% 1
2024
Q3
$60.2M Buy
530,510
+10,827
+2% +$1.29M 8.95% 1
2024
Q2
$64.3M Sell
519,683
-9,918
-2% -$1.28M 19.62% 1
2024
Q1
$69.9M Sell
529,601
-17,933
-3% -$2.21M 11.92% 1
2023
Q4
$59.7M Sell
547,534
-17,248
-3% -$1.79M 11.13% 1
2023
Q3
$58.1M Sell
564,782
-6,895
-1% -$743K 11.57% 1
2023
Q2
$66M Sell
571,677
-15,468
-3% -$1.76M 28.19% 1
2023
Q1
$62.5M Sell
587,145
-6,783
-1% -$732K 16.43% 1
2022
Q4
$65.9M Sell
593,928
-710
-0.1% -$72.6K 16.12% 1
2022
Q3
$51.2M Buy
594,638
+281
+0% +$25.1K 14.85% 1
2022
Q2
$54.2M Sell
594,357
-20,521
-3% -$1.82M 14.82% 1
2022
Q1
$50.5M Sell
614,878
-29,280
-5% -$2.31M 12.66% 1
2021
Q4
$49.4M Sell
644,158
-15,383
-2% -$1.23M 12.19% 1
2021
Q3
$49.5M Buy
659,541
+42,158
+7% +$3.21M 29.42% 1
2021
Q2
$48M Sell
617,383
-28,534
-4% -$2.12M 16.21% 1
2021
Q1
$47.5M Sell
645,917
-344,935
-35% -$25.4M 15.28% 1
2020
Q4
$77.3M Buy
990,852
+351,978
+55% +$26.9M 21.82% 1
2020
Q3
$50.6M Sell
638,874
-2,078
-0.3% -$163K 16.94% 1
2020
Q2
$47.8M Sell
640,952
-1,238
-0.2% -$93.2K 17.26% 1
2020
Q1
$47.1M Sell
642,190
-18,759
-3% -$1.47M 19.35% 1
2019
Q4
$57.4M Sell
660,949
-5,463
-0.8% -$449K 17.78% 1
2019
Q3
$53.5M Buy
666,412
+5,579
+0.8% +$447K 17.54% 1
2019
Q2
$52.9M Sell
660,833
-23,690
-3% -$1.81M 17.4% 1
2019
Q1
$54.3M Sell
684,523
-34,647
-5% -$2.59M 17.78% 1
2018
Q4
$52.4M Sell
719,170
-10,441
-1% -$737K 18.92% 1
2018
Q3
$49.4M Buy
729,611
+15,163
+2% +$966K 15.71% 1
2018
Q2
$41.4M Sell
714,448
-40,631
-5% -$2.29M 15.34% 1
2018
Q1
$39.2M Sell
755,079
-1,399
-0.2% -$75.6K 13.34% 1
2017
Q4
$40.6M Buy
756,478
+493
+0.1% +$27.3K 13% 1
2017
Q3
$46.2M Hold
755,985
15.65% 1
2017
Q2
$46.2M Sell
755,985
-11,623
-2% -$708K 15.65% 1
2017
Q1
$46.5M Sell
767,608
-44,120
-5% -$2.68M 15.72% 1
2016
Q4
$45.6M Buy
+811,728
New +$47.5M 15.6% 1

Other funds holding MRK

Radnor Capital Management's MRK Position: Q2 2026 in Review

Radnor Capital Management reduced its Merck (MRK) stake by 0.1% in Q2 2026, selling an estimated $63.6K and leaving 518,900 shares worth $66.7M. The position accounts for 9.36% of the portfolio, ranked #1.

Radnor Capital Management first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. The position peaked at $77.3M in Q4 2020. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Radnor Capital Management held 518,900 shares of Merck worth $66.7M as of Q2 2026.
  • Radnor Capital Management sold 543 Merck shares in Q2 2026, an estimated $63.6K.
  • Merck made up 9.36% of Radnor Capital Management's portfolio in Q2 2026, its #1 holding.
  • Radnor Capital Management first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
  • Radnor Capital Management's Merck position peaked at $77.3M in Q4 2020.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.